Skip to main content
Premium Trial:

Request an Annual Quote

A 'Willful' Foe

Premium

For a while, scientists have been basing their cancer research on the idea that a single cell accumulated gene mutations and develops into a malignant tumor. However, this article in The New York Times says that "cancer appears to be even more willful and calculating than previously imagined." Researchers are now studying microRNAs interfere with communication signals between cells and how the microbiome — all those microbes that live in and on the body — can influence how host cells act. "The enemy inside us is every bit as formidable as imagined invaders from beyond. Learning to outwit it is leading science deep into the universe of the living cell," the Times says.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.